Cardiac fibrosis plays an indispensable role in cardiac tissue homeostasis and repair after
myocardial infarction (MI). The cardiac fibroblast-to-myofibroblast differentiation and …

Inflammation involves the activation of innate immune cells and is believed to play an
important role in the development and progression of both infectious and non-infectious …

The development of new immunotherapies to treat the inflammatory mechanisms that
sustain atherosclerotic cardiovascular disease (ASCVD) is urgently needed. Herein, we …

Cardiovascular diseases (CVD) is a collective term describing a range of conditions that
affect the heart and blood vessels. Due to the varied nature of the disorders, distinguishing …

Growing evidence implicates the immune system as a critical mediator of cardiovascular
disease progression and a viable therapeutic target. Increased inflammatory cell activity is …

Assessing atherosclerosis severity is essential for precise patient stratification. Specifically,
there is a need to identify patients with residual inflammation because these patients remain …

Fibrosis is a common healing process that occurs during stress and injury in cardiovascular
diseases. The evolution of fibrosis is associated with cardiovascular disease states and …

Inflammation is an important component of several chronic and debilitating diseases that
result in significant morbidity and mortality. This is best evidenced within the cardiovascular …

Atherosclerosis is a chronic systemic inflammatory condition of the vasculature and a
leading cause of stroke. Luminal stenosis severity is an important factor in determining …

Myocardial inflammation plays a central role in the pathophysiology of various cardiac
diseases. While FDG-PET is currently the primary method for molecular imaging of …